Hyperlipidemia and mortality in patients on peritoneal dialysis.

ABSTRACT:

Background

New lipid-lowering therapy at the start of dialysis and measurement of lipid parameters over the follow-up period is not recommended in dialysis patients, which seems unappropriated in clinical practice. We aimed to examine the effect of hyperlipidemia on mortality in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).

Methods

A retrospective cohort study was performed, including 2939 incident CAPD patients from five dialysis facilities between January 1, 2005, and December 31, 2018. The primary outcome was all-cause mortality. The association between hyperlipidemia at the start of CAPD and all-cause mortality was evaluated using Cox proportional hazards regression.

Results

Of 2939 with a median age of 50.0 (interquartile range, 39.0-61.0)

SUBMITTER: Feng X 

PROVIDER: S-EPMC9590170 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature